Skip to content
Tenfell
Awarded contract
Published 07 Apr 2026

NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives

NHS England · London

Key facts

Awarded
11 Mar 2026
Contract starts
31 Mar 2026
Contract ends
31 Mar 2028
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 2 suppliers

SupplierValue
Abbvie Ltd—
Gilead Sciences Limited—

Description

Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026 Offer reference number: CM/TNS/25/5737 Period of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.